{"id":2832,"date":"2020-09-21T14:00:00","date_gmt":"2020-09-21T14:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/forandringar-i-xvivo-perfusions-ledningsgrupp\/"},"modified":"2020-09-21T14:00:00","modified_gmt":"2020-09-21T14:00:00","slug":"forandringar-i-xvivo-perfusions-ledningsgrupp","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/","title":{"rendered":"F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp"},"content":{"rendered":"
\n

XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) meddelar idag att bolagets CFO Christoffer Rosenblad har utn\u00e4mnts till en nyinr\u00e4ttad tj\u00e4nst inom XVIVO som Chief Operating Officer, COO. Ny CFO blir Kristoffer Nordstr\u00f6m, XVIVOs nuvarande ekonomichef. F\u00f6r\u00e4ndringarna tr\u00e4der i kraft den 1 december 2020. Christoffer Rosenblad kvarst\u00e5r \u00e4ven som Vice VD med ansvar f\u00f6r Investor Relations.<\/strong><\/p>\n<\/div>\n

\n

Inr\u00e4ttandet av en ny tj\u00e4nst som COO \u00e4r ett led i den f\u00f6rst\u00e4rkning av XVIVOs ledningsgrupp som p\u00e5b\u00f6rjades den 4 september 2020 i samband med tills\u00e4ttandet av en ny kommersiell direkt\u00f6r och en ny forsknings- och utvecklingsdirekt\u00f6r.<\/p>\n

\u201dXVIVO har under Christoffers \u00e5tta \u00e5r som CFO h\u00e5llit ett starkt fokus p\u00e5 l\u00f6nsamhet och tillv\u00e4xt\u201d, s\u00e4ger XVIVOs VD Dag Andersson i en kommentar till utn\u00e4mningen. \u201dDet \u00e4r ett naturligt steg f\u00f6r Christoffer att anta nya utmaningar och ta p\u00e5 sig en mer operativ roll i bolaget\u201d.<\/p>\n

Kristoffer Nordstr\u00f6m har varit anst\u00e4lld p\u00e5 XVIVO i tre \u00e5r och har dessf\u00f6rinnan 10 \u00e5rs erfarenhet som auktoriserad revisor p\u00e5 KPMG.<\/p>\n

\u201dKristoffer har under sin tid p\u00e5 XVIVO ansvarat f\u00f6r flera av de uppgifter som faller p\u00e5 en CFO i ett noterat bolag\u201d, konstaterar VD Dag Andersson. \u201dHan \u00e4r d\u00e4rf\u00f6r redo att anta rollen som CFO fullt ut\u201d.<\/p>\n

Den beslutade omorganisationen, varav inr\u00e4ttandet av en ny tj\u00e4nst som COO \u00e4r en del, ber\u00f6r bolagets samtliga avdelningar och har till syfte att skapa en mer effektiv och \u00e4ndam\u00e5lsinriktad verksamhet. Kostnaden f\u00f6r omorganisationen redovisas under tredje kvartalet 2020 och ber\u00e4knas p\u00e5verka EBITDA negativt med 5,0 MSEK.<\/p>\n

\u201dI och med denna omorganisation har vi lagt den grund som kr\u00e4vs f\u00f6r att st\u00e4rka och utveckla v\u00e5r v\u00e4rldsledande position inom organtransplantation och leverera enligt v\u00e5r strategi\u201d, konstaterar Dag Andersson.<\/p>\n

G\u00f6teborg den 21 september 2020<\/p>\n

Dag Andersson<\/p>\n<\/div>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta:<\/strong><\/p>\n\n

Christoffer Rosenblad, CFO, +46 73-519 21 59,\u00a0christoffer.rosenblad@xvivoperfusion.com<\/a>
Dag Andersson, VD, +46 31-788 21 50,\u00a0dag.andersson@xvivoperfusion.com<\/a><\/p>\n<\/div>\n

\n

Om oss<\/strong><\/p>\n\n

XVIVO Perfusion AB \u00e4r ett medicinteknikbolag som utvecklar l\u00f6sningar och system f\u00f6r att bed\u00f6ma och bevara organ utanf\u00f6r kroppen, och f\u00f6r att selektera anv\u00e4ndbara organ och h\u00e5lla dem i optimal kondition i v\u00e4ntan p\u00e5 transplantation. XVIVO Perfusion AB har sitt huvudkontor i G\u00f6teborg och ytterligare kontor finns i Lund och i Denver, USA. XVIVO-aktien \u00e4r noterad p\u00e5 Nasdaq Stockholm och handlas under symbolen XVIVO.
Mer information finns att l\u00e4sa p\u00e5 hemsidan www.xvivoperfusion.com.<\/a><\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n\n

F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) meddelar idag att bolagets CFO Christoffer Rosenblad har utn\u00e4mnts till en nyinr\u00e4ttad tj\u00e4nst inom XVIVO…<\/p>\n","protected":false},"template":"","class_list":["post-2832","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-staff"],"acf":[],"yoast_head":"\nF\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) meddelar idag att bolagets CFO Christoffer Rosenblad har utn\u00e4mnts till en nyinr\u00e4ttad tj\u00e4nst inom XVIVO...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandringar-i-xvivo-perfusions-ledningsgrupp\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandringar-i-xvivo-perfusions-ledningsgrupp\\\/\",\"name\":\"F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-09-21T14:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandringar-i-xvivo-perfusions-ledningsgrupp\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandringar-i-xvivo-perfusions-ledningsgrupp\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandringar-i-xvivo-perfusions-ledningsgrupp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/","og_locale":"en_US","og_type":"article","og_title":"F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp - XVIVO","og_description":"XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) meddelar idag att bolagets CFO Christoffer Rosenblad har utn\u00e4mnts till en nyinr\u00e4ttad tj\u00e4nst inom XVIVO...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/","name":"F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-09-21T14:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandringar-i-xvivo-perfusions-ledningsgrupp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"F\u00f6r\u00e4ndringar i XVIVO Perfusions ledningsgrupp"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}